942 related articles for article (PubMed ID: 12441176)
1. Mechanisms involved in the side effects of glucocorticoids.
Schäcke H; Döcke WD; Asadullah K
Pharmacol Ther; 2002 Oct; 96(1):23-43. PubMed ID: 12441176
[TBL] [Abstract][Full Text] [Related]
2. Dissociation of transactivation from transrepression by a selective glucocorticoid receptor agonist leads to separation of therapeutic effects from side effects.
Schäcke H; Schottelius A; Döcke WD; Strehlke P; Jaroch S; Schmees N; Rehwinkel H; Hennekes H; Asadullah K
Proc Natl Acad Sci U S A; 2004 Jan; 101(1):227-32. PubMed ID: 14694204
[TBL] [Abstract][Full Text] [Related]
3. SEGRAs: a novel class of anti-inflammatory compounds.
Schäcke H; Hennekes H; Schottelius A; Jaroch S; Lehmann M; Schmees N; Rehwinkel H; Asadullah K
Ernst Schering Res Found Workshop; 2002; (40):357-71. PubMed ID: 12355726
[TBL] [Abstract][Full Text] [Related]
4. Classic glucocorticoids versus non-steroidal glucocorticoid receptor modulators: survival of the fittest regulator of the immune system?
De Bosscher K; Beck IM; Haegeman G
Brain Behav Immun; 2010 Oct; 24(7):1035-42. PubMed ID: 20600811
[TBL] [Abstract][Full Text] [Related]
5. [Glucocorticoids and their receptor: mechanisms of action and clinical implications].
Roumestan C; Gougat C; Jaffuel D; Mathieu M
Rev Med Interne; 2004 Sep; 25(9):636-47. PubMed ID: 15363619
[TBL] [Abstract][Full Text] [Related]
6. Targeting glucocorticoid side effects: selective glucocorticoid receptor modulator or glucocorticoid-induced leucine zipper? A perspective.
Ayroldi E; Macchiarulo A; Riccardi C
FASEB J; 2014 Dec; 28(12):5055-70. PubMed ID: 25205742
[TBL] [Abstract][Full Text] [Related]
7. Separating transrepression and transactivation: a distressing divorce for the glucocorticoid receptor?
Newton R; Holden NS
Mol Pharmacol; 2007 Oct; 72(4):799-809. PubMed ID: 17622575
[TBL] [Abstract][Full Text] [Related]
8. Glucocorticoid Receptor Transactivation Is Required for Glucocorticoid-Induced Ocular Hypertension and Glaucoma.
Patel GC; Millar JC; Clark AF
Invest Ophthalmol Vis Sci; 2019 May; 60(6):1967-1978. PubMed ID: 31050723
[TBL] [Abstract][Full Text] [Related]
9. The glucocorticoid receptor agonistic modulators CpdX and CpdX-D3 do not generate the debilitating effects of synthetic glucocorticoids.
Hua G; Zein N; Paulen L; Chambon P
Proc Natl Acad Sci U S A; 2019 Jul; 116(28):14200-14209. PubMed ID: 31221758
[TBL] [Abstract][Full Text] [Related]
10. Dissociated glucocorticoid receptor ligands.
Schäcke H; Rehwinkel H
Curr Opin Investig Drugs; 2004 May; 5(5):524-8. PubMed ID: 15202726
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic Mechanisms of Glucocorticoids.
Vandewalle J; Luypaert A; De Bosscher K; Libert C
Trends Endocrinol Metab; 2018 Jan; 29(1):42-54. PubMed ID: 29162310
[TBL] [Abstract][Full Text] [Related]
12. New insights into the anti-inflammatory mechanisms of glucocorticoids: an emerging role for glucocorticoid-receptor-mediated transactivation.
Vandevyver S; Dejager L; Tuckermann J; Libert C
Endocrinology; 2013 Mar; 154(3):993-1007. PubMed ID: 23384835
[TBL] [Abstract][Full Text] [Related]
13. Optimized glucocorticoid therapy: teaching old drugs new tricks.
Strehl C; Buttgereit F
Mol Cell Endocrinol; 2013 Nov; 380(1-2):32-40. PubMed ID: 23403055
[TBL] [Abstract][Full Text] [Related]
14. New insights into the novel anti-inflammatory mode of action of glucocorticoids.
Ingawale DK; Mandlik SK
Immunopharmacol Immunotoxicol; 2020 Apr; 42(2):59-73. PubMed ID: 32070175
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic benefit of a dissociated glucocorticoid and the relevance of in vitro separation of transrepression from transactivation activity.
Belvisi MG; Wicks SL; Battram CH; Bottoms SE; Redford JE; Woodman P; Brown TJ; Webber SE; Foster ML
J Immunol; 2001 Feb; 166(3):1975-82. PubMed ID: 11160246
[TBL] [Abstract][Full Text] [Related]
16. Ginsenoside Rg1, a novel glucocorticoid receptor agonist of plant origin, maintains glucocorticoid efficacy with reduced side effects.
Du J; Cheng B; Zhu X; Ling C
J Immunol; 2011 Jul; 187(2):942-50. PubMed ID: 21666059
[TBL] [Abstract][Full Text] [Related]
17. Selective glucocorticoid receptor modulation: New directions with non-steroidal scaffolds.
Sundahl N; Bridelance J; Libert C; De Bosscher K; Beck IM
Pharmacol Ther; 2015 Aug; 152():28-41. PubMed ID: 25958032
[TBL] [Abstract][Full Text] [Related]
18. Identification of novel in vitro test systems for the determination of glucocorticoid receptor ligand-induced skin atrophy.
Schoepe S; Schäcke H; Bernd A; Zöller N; Asadullah K
Skin Pharmacol Physiol; 2010; 23(3):139-51. PubMed ID: 20051715
[TBL] [Abstract][Full Text] [Related]
19. Dissociated steroids.
Catley M
ScientificWorldJournal; 2007 Mar; 7():421-30. PubMed ID: 17450306
[TBL] [Abstract][Full Text] [Related]
20. [Mechanisms of action of glucocorticoids].
Dejean C; Richard D
Rev Med Interne; 2013 May; 34(5):264-8. PubMed ID: 23498716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
